Community Pharmacy COVID-19 Vaccination Programme Phase 5 2023/24

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-03b1f0-2023-03-10T15:08:06Z",
    "date": "2023-03-10T15:08:06Z",
    "ocid": "ocds-h6vhtk-03b1f0",
    "description": "This is a voluntary Contract Notice. LES Agreements are authorised pursuant to direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. In any event, the services in scope are healthcare services which fall under \"social and other specific services\" in Section 7.. All Pharmacy Contractors that submit Expressions of Interest will set out in Stage 1 of Designation Process (as set out in the Community Pharmacy Phase 5 Designation Process document) will then go through a prioritisation process with the application of locality specific criteria to identify Priority Sites which will then go through an assurance process. Any such Assured Sites will then be subject to an assessment of readiness preparation with NHS England. Where NHS England is so satisfied, the site will be approved and a LES Agreement offered. If NHS England considers that there is a need for additional COVID-19 vaccination services in a geographical area covered by the Pharmacy Contractor who submitted an Expression of Interest, NHS England may either publish an invitation to submit new Expressions of Interest with specific detail as to the specific requirements or revisit the Expressions of Interest originally submitted and progress other Pharmacy Contractors through the Designation Process again. There will be no maximum number of Pharmacy Contractors that may be offered a LES Agreement. Each LES Agreement is likely to be below the financial threshold for services.",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-03b1f0",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Community Pharmacy COVID-19 Vaccination Programme Phase 5 2023/24",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "85100000",
            "description": "Health services"
        },
        "mainProcurementCategory": "services",
        "description": "The National Health Service Commissioning Board (which uses the operational name \"NHS England\") is seeking to enter into local enhanced services arrangements with community pharmacies in geographical areas where NHS England identifies there is a need for additional COVID-19 vaccination capacity. Successful community pharmacies will provide COVID-19 vaccination services under a local enhanced services agreement at designated sites operated by the pharmacies.<br/><br/>Coronavirus \" COVID-19 vaccination enhanced service specification for autumn/winter 2022 for community pharmacy (england.nhs.uk)<br/><br/>https://cv19pharmacyeoi.necsu.nhs.uk/",
        "value": {
            "amount": 10.06,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "NHS is a global leader in achieving high levels of vaccination coverage, and this has been reflected in a hugely successful COVID-19 vaccination programme. Community pharmacy has played a critical role in the success of the COVID-19 vaccination programme. Through their strong relationships in local places and neighbourhoods, community pharmacies have helped to tackle vaccine inequalities and improve vaccination take-up.<br/>The fifth phase of the COVID-19 vaccination programme will offer booster (with additional vaccine) for those at the highest risk, to maintain protection against the risk of severe illness, and continue to offer initial vaccinations to those Patients who did not take up or were previously not eligible to receive vaccination in previous phases.<br/>The service will be provided as a Local Enhanced Service (LES) pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. The Community Pharmacy Phase 5 Site Designation Process document sets out the detail of how Pharmacy Contractor can submit expressions of interest for providing the LES and how Pharmacy Contractors who are able to provide the LES will be identified at a regional basis based on site. The LES Agreement document sets out the requirements of service provision. A LES Agreement will be entered into between NHS England and a Pharmacy Contractor selected by NHS England via the Site Designation Process which is set out in the Community Pharmacy Phase 5 Site Designation Process document but only where there is a local population need for additional COVID-19 vaccination services and where NHS England considers the relevant Pharmacy Contractor is best placed to meet that need having applies the criteria, process and steps outlined in the Community Pharmacy Phase 5 Site Designation Process document.<br/>For the avoidance of doubt, this is a voluntary Contract Notice in the interests of achieving maximum transparency and sectoral awareness. NHS England is empowered to facilitate LES Agreements on a site-by-site basis pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013.<br/>The items of service payment of PS10.06 per vaccination administered to a Patient.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "value": {
                    "amount": 10.06,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "durationInDays": 90
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": false,
                "status": "active"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85323000",
                        "description": "Community health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "submissionMethod": [
            "electronicSubmission",
            "written"
        ],
        "submissionMethodDetails": "https://health-family.force.com/s/Welcome",
        "communication": {
            "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
        },
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Pursuant to direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013, NHS England is only authorised to arrange for the provision of an enhanced service with Pharmacy Contractors which are defined as persons included in a list prepared under regulation 10(2)(a) of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
                    "appliesTo": [
                        "supplier"
                    ]
                }
            ]
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "coveredBy": [
            "GPA"
        ],
        "tenderPeriod": {
            "endDate": "2023-03-17T12:00:00Z"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "awardPeriod": {
            "startDate": "2023-03-17T12:00:00Z"
        },
        "bidOpening": {
            "date": "2023-03-17T12:00:00Z"
        },
        "hasRecurrence": true
    },
    "parties": [
        {
            "id": "GB-FTS-67205",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "1st Floor, Quarry House, Quarry Hill",
                "locality": "Leeds",
                "region": "UKE",
                "postalCode": "LS2 7UE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Janice Brodie",
                "email": "janice.brodie@nhs.net",
                "url": "https://health-family.force.com/s/Welcome"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk//",
                "buyerProfile": "https://www.england.nhs.uk//",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "NATIONAL_AGENCY",
                        "description": "National or federal agency/office"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-1661",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "streetAddress": "The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-67205",
        "name": "NHS England"
    },
    "language": "en"
}